Clinical Focus Series: Difficult Asthma Clinical Focus Series

Most patients with asthma are easily diagnosed and treated with the use of an inhaler or medication.  Approximately five per cent of people that suffer from asthma have ‘difficult’ or ‘refractory’ asthma, whereby they experience persistent problems that are not controlled by standard treatment methods.

Part of the Clinical Focus Series, this book provides a complete overview of difficult asthma, discussing the clinical assessment and management of this complex condition.

Beginning with the epidemiology and characteristics of severe asthma, the book defines current understanding of the immunological mechanisms and disease heterogeneity. It also offers insight into how the condition can affect the physical and psychological aspects of a person’s life. Separate chapters examine novel therapeutic strategies and the economic burden of refractory asthma.

Key points

• Discusses clinical assessment and management of difficult asthma
• Includes epidemiology, immunology, physical and psychological effects, economic burden and novel therapeutics
• Internationally renowned author and editor team

• Definition, Epidemiology, and Phenotypes of Severe Asthma
• The Economic Burden of Difficult Asthma
• Clinical Assessment of Difficult Asthma
• Adherence in Difficult Asthma
• Psychological Morbidity in Difficult to Treat Asthma
• Difficult Asthma in Children
• Difficult Asthma – The Patient’s Perspective
• Co-morbidity in Refractory Asthma
• Molecular and Immunological Basis for Severe Therapy-resistant Asthma
• Monitoring and Natural History of Refractory Asthma

• Novel Treatment Strategies in Refractory Asthma

Liam Heaney MD MRCP
Senior Lecturer, Respiratory Medicine Research Group, Centre for Infection and Immunity, The Queen's University of Belfast, Northern Ireland

Andrew Menzies PhD FRCP
Consultant, Royal Brompton and Harefield NHS Foundation Trust, London, UK